The human system can be quantified, manipulated, and optimized. The human drive to self-improve is timeless, but modern technologies now allow us to enhance in precise and measurable ways like never before.
As a group of biohackers, technologists, and researchers, we believe life should be lived to its fullest potential. That potential is tested and ultimately judged by the work we produce. We’ve realized that the world around us is made by people no smarter than you or me, and we too can make a dent in the world with what we can create.
When it comes to our offerings, we take the same mentality. Nootrobox researches, develops, and manufactures nootropics with state of the art manufacturing techniques and 100% FDA generally regarded as safe (GRAS) components. This guarantees nootropics that are effective, precise, and safe.
We’re driving some of the latest research with top academic collaborators in the world to better understand human cognition and biohacking. This expertise and data is used to constantly evolve and improve our offerings. Thus, our products and formulations are at the forefront of the latest science and research.
Our goal is to make nootropics for everyone. A smarter society is a better society, so let’s build and live in that future together.
Nootropics are a broad classification of cognition-enhancing compounds that produce minimal side effects and are suitable for long-term use.
Cognition is the set of all mental abilities and processes related to knowledge and decision making. There are many aspects of cognition that can be independently measured and studied.
The Biohacker Guide from Nootrobox is the definitive biohacking resource and guide. There's tremendously exciting research in the areas of cognitive modulation, biohacking, and human enhancement.
Sign up to receive weekly emails from Geoff. Learn the science of motivation and how to optimize every day of your life, plus stay in the loop for news about biohacking, nootropics, and new scientific findings.
We sent free samples to journalists at their request for diligence and reporting on nootropics. Here's what a few had to say: